...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: IP considerations may prevent RVX from disclosing eGFR data

No, I was giving you an example of why a patent would be registered as was done with ABL + Crestor (generic), a few years back, which has nothing to do with eGFR.  

BKC stated: " It could just as well be related to RVX trying to patent an effect we have not yet heard about." (bolding added)

Koo

Share
New Message
Please login to post a reply